FABP4, fatty acid binding protein 4, 2167

N. diseases: 194; N. variants: 5
Disease: Carotid Atherosclerosis ×
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0577631
Disease: Carotid Atherosclerosis
Carotid Atherosclerosis 		0.050 Biomarker disease BEFREE FABP4 concentration is an independent predictor of the progression of carotid atherosclerosis. 29445067 2018
CUI: C0577631
Disease: Carotid Atherosclerosis
Carotid Atherosclerosis 		0.050 Biomarker disease BEFREE In conclusion, in contrast to FABP4, circulating FABP5 is associated with decreased CEC and carotid atherosclerosis, suggesting that FABP5 level is a regulatory factor of CEC and a potential biomarker for residual risk of atherosclerosis. 28303004 2017
CUI: C0577631
Disease: Carotid Atherosclerosis
Carotid Atherosclerosis 		0.050 AlteredExpression disease BEFREE We investigated the effects of this low-expression variant of FABP4 on cardiovascular morbidity and carotid atherosclerosis on a population level (n=7491) and in patient cohorts representing endarterectomized patients with advanced carotid atherosclerosis (n=92) and myocardial infarction (n=3432). 25122052 2014
CUI: C0577631
Disease: Carotid Atherosclerosis
Carotid Atherosclerosis 		0.050 AlteredExpression disease BEFREE Expression of fatty acid-binding protein 4/aP2 is correlated with plaque instability in carotid atherosclerosis. 21073559 2011
CUI: C0577631
Disease: Carotid Atherosclerosis
Carotid Atherosclerosis 		0.050 Biomarker disease BEFREE FABP4 is linked to atherogenesis, plaque instability and adverse outcome in patients with carotid atherosclerosis and acute ischemic stroke. 22174896 2011